A new trading day began on Monday, with Alzamend Neuro Inc (NASDAQ: ALZN) stock price down -8.62% from the previous day of trading, before settling in for the closing price of $3.83. ALZN’s price has ranged from $3.06 to $135.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 89.05%. With a float of $0.77 million, this company’s outstanding shares have now reached $0.80 million.
In an organization with 7 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 66.67%, operating margin of -5528.78%, and the pretax margin is -5553.72%.
Alzamend Neuro Inc (ALZN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alzamend Neuro Inc is 4.22%, while institutional ownership is 0.88%. The most recent insider transaction that took place on May 12 ’25, was worth 6,138. In this transaction Director of this company sold 1,213 shares at a rate of $5.06, taking the stock ownership to the 8,260 shares. Before that another transaction happened on May 12 ’25, when Company’s Director sold 11 for $5.28, making the entire transaction worth $58. This insider now owns 1,843 shares in total.
Alzamend Neuro Inc (ALZN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 89.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 61.95% during the next five years compared to -11.45% drop over the previous five years of trading.
Alzamend Neuro Inc (NASDAQ: ALZN) Trading Performance Indicators
Here are Alzamend Neuro Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -27.58, a number that is poised to hit -3.38 in the next quarter and is forecasted to reach -10.98 in one year’s time.
Technical Analysis of Alzamend Neuro Inc (ALZN)
Let’s dig in a bit further. During the last 5-days, its volume was 16.21 million. That was better than the volume of 0.88 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.96%. Additionally, its Average True Range was 0.87.
During the past 100 days, Alzamend Neuro Inc’s (ALZN) raw stochastic average was set at 5.14%, which indicates a significant decrease from 8.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 283.98% in the past 14 days, which was higher than the 134.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.21, while its 200-day Moving Average is $11.57. However, in the short run, Alzamend Neuro Inc’s stock first resistance to watch stands at $3.77. Second resistance stands at $4.05. The third major resistance level sits at $4.19. If the price goes on to break the first support level at $3.36, it is likely to go to the next support level at $3.23. The third support level lies at $2.95 if the price breaches the second support level.
Alzamend Neuro Inc (NASDAQ: ALZN) Key Stats
With a market capitalization of 2.81 million, the company has a total of 801K Shares Outstanding. Currently, annual sales are 0 K while annual income is -9,950 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,040 K.